Age affects pegylated liposomal doxorubicin elimination and tolerability in patients over 70 years old.
Gusella M, Bononi A, Modena Y, Bertolaso L, Franceschetti P, Menon D, Pezzolo E, Barile C, Crepaldi G, Bolzonella C, Inno A, Padrini R, Pasini F.
Gusella M, et al.
Cancer Chemother Pharmacol. 2014 Mar;73(3):517-24. doi: 10.1007/s00280-014-2378-z. Epub 2014 Jan 18.
Cancer Chemother Pharmacol. 2014.
PMID: 24442033
Clinical Trial.